Update on long-term outcomes of a cohort of patients with TCF3::HLF positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantationAida Zečkanović, Jean‐Pierre Bourquin, Brice Mouttet et al.|Haematologica|2025Cited by 3
Drug Response Profiling Informs Personalized Bridging to Cell Therapy for Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaFabio D. Steffen, Jean‐Pierre Bourquin, Adriana Balduzzi et al.|Blood|2023Cited by 1
Update on long-term outcomes of a cohort of patients with -positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantationAida Zečkanović, Jean-Pierre Bourquin, Brice Mouttet et al.|Open MIND|2025Cited by 0